Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02414347 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT02414347 · ClinicalTrials.gov record · last posted 2026-06-08

F 18 T807 Tau PET Imaging of Alzheimer's Disease

Study acronym: T807IND
StatusRecruiting
PhaseNot specified
Started2014-10-23
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
A single-center, open-label baseline controlled imaging study designed to assess whether brain tau fibril uptake of flortaucipir as measured by PET correlates with cognitive status of individuals with and without brain tau fibrils.

Amendment record 14 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 14 times since 2015-04-09; most recent amendment 2026-06-04. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-09-02
Status change Active, Not Recruiting→Recruitingv10
2020-05-28
Status change Enrolling by Invitation→Active, Not Recruitingv7
2018-06-25
Status change Recruiting→Enrolling by Invitationv4
Trial Details
NCT Number NCT02414347
Lead Sponsor Tammie L. S. Benzinger, MD, PhD
Conditions Alzheimer Disease
Enrollment 900 participants
Start Date 2014-10-23
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-08